Debt - Additional Information (Details) - USD ($) |
8 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
May 29, 2025 |
Aug. 23, 2024 |
Dec. 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 08, 2023 |
|
| Debt Instrument [Line Items] | ||||||
| Weighted average interest rate | 8.41% | 6.91% | 8.67% | |||
| Weighted average debt outstanding | $ 2,241,000 | $ 201,372,000 | $ 73,192,000 | |||
| Aggregate Principal Amount Committed | 575,000,000 | 150,000,000 | ||||
| Deferred financing costs, net | $ 6,873,000 | 1,413,000 | ||||
| JPM Funding Facility | ||||||
| Debt Instrument [Line Items] | ||||||
| Line of credit facility, maturity date, description | On December 8, 2023, the Company entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility”), as servicer, with CPCI Funding SPV, LLC, the Company’s wholly owned subsidiary (the “Borrower I”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $375,000 with a reinvestment period ending December 8, 2026 and a final maturity date of December 8, 2028. | |||||
| Debt instrument, offering date | Dec. 08, 2023 | |||||
| Aggregate Principal Amount Committed | 150,000,000 | $ 375,000,000 | ||||
| Debt instrument, reinvestment period ending date | Dec. 08, 2026 | |||||
| Debt instrument, maturity date | Dec. 08, 2028 | |||||
| Increase in borrowing capacity | $ 500,000,000 | |||||
| Line of credit facility, interest rate description | plus a margin of 2.13% | |||||
| Interest Rate, Floor | 2.13% | |||||
| JPM Funding Facility | Maximum | ||||||
| Debt Instrument [Line Items] | ||||||
| Increase in borrowing capacity | $ 375,000,000 | |||||
| Interest Rate, Floor | 2.25% | 2.60% | ||||
| JPM Funding Facility | Minimum | ||||||
| Debt Instrument [Line Items] | ||||||
| Increase in borrowing capacity | $ 150,000,000 | |||||
| Interest Rate, Floor | 2.13% | 2.25% | ||||
| JPM Funding Facility II | ||||||
| Debt Instrument [Line Items] | ||||||
| Line of credit facility, maturity date, description | On March 31, 2025, the Company entered into a Loan and Security Agreement (as amended, the “JPM Funding Facility II”), as servicer, with CPCI Funding SPV II, LLC, the Company’s wholly owned subsidiary (the “Borrower II” and together with Borrower I, the “Borrowers”), as borrower, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provided a secured credit facility of $100,000 with a reinvestment period ending September 30, 2027 and a final maturity date of March 31, 2028. | |||||
| Debt instrument, offering date | Mar. 31, 2025 | |||||
| Aggregate Principal Amount Committed | $ 100,000,000 | |||||
| Debt instrument, reinvestment period ending date | Sep. 30, 2027 | |||||
| Debt instrument, maturity date | Mar. 31, 2028 | |||||
| Increase in borrowing capacity | $ 200,000,000 | |||||
| Line of credit facility, interest rate description | plus a margin of 1.35% | |||||
| Interest Rate, Floor | 1.35% | |||||
| JPM Funding Facility III | ||||||
| Debt Instrument [Line Items] | ||||||
| Line of credit facility, maturity date, description | On October 17, 2025, the Company entered into a Loan and Security Agreement (the “JPM Funding Facility III” and together with the JPM Funding Facility and the JPM Funding Facility II, the “credit facilities”), as servicer, with the borrowers, the lenders party thereto, U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, U.S. Bank National Association, as securities intermediary, and JPMorgan Chase Bank, National Association, as administrative agent, that provides a secured credit facility of $575,000 with a reinvestment period ending October 17, 2028 and a final maturity date of October 17, 2030. | |||||
| Debt instrument, offering date | Oct. 17, 2025 | |||||
| Aggregate Principal Amount Committed | $ 575,000,000 | |||||
| Debt instrument, reinvestment period ending date | Oct. 17, 2028 | |||||
| Debt instrument, maturity date | Oct. 17, 2030 | |||||
| Increase in borrowing capacity | $ 875,000,000 | |||||
| Line of credit facility, interest rate description | plus a margin of (i) 1.35% (or 1.4693% in the case of borrowings in British Pounds) or (ii) 1.90% (or 2.0193% in the case of borrowings in British Pounds) | |||||
| Deferred financing costs, net | $ 6,873,000 | $ 0 | ||||
| JPM Funding Facility III | Maximum | SOFR | ||||||
| Debt Instrument [Line Items] | ||||||
| Interest Rate, Floor | 1.90% | |||||
| JPM Funding Facility III | Maximum | Borrowings in British Pounds | ||||||
| Debt Instrument [Line Items] | ||||||
| Interest Rate, Floor | 2.0193% | |||||
| JPM Funding Facility III | Minimum | SOFR | ||||||
| Debt Instrument [Line Items] | ||||||
| Interest Rate, Floor | 1.35% | |||||
| JPM Funding Facility III | Minimum | Borrowings in British Pounds | ||||||
| Debt Instrument [Line Items] | ||||||
| Interest Rate, Floor | 1.4693% | |||||